These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2096832)
1. Brain and CSF specific chemical delivery systems for beta-lactam antibiotics. Study of two dihydropyridine derivatives of benzylpenicillin in rabbits and dogs. Wu WM; Pop E; Shek E; Clemmons R; Bodor N Drug Des Deliv; 1990 Dec; 7(1):33-43. PubMed ID: 2096832 [TBL] [Abstract][Full Text] [Related]
2. Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats. Wu WM; Pop E; Shek E; Bodor N J Med Chem; 1989 Aug; 32(8):1782-8. PubMed ID: 2754705 [TBL] [Abstract][Full Text] [Related]
3. 1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain. Hassan HA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH Bioorg Med Chem; 2009 Feb; 17(4):1681-92. PubMed ID: 19147368 [TBL] [Abstract][Full Text] [Related]
4. Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin. Pop E; Wu WM; Shek E; Bodor N J Med Chem; 1989 Aug; 32(8):1774-81. PubMed ID: 2754704 [TBL] [Abstract][Full Text] [Related]
5. Improved delivery through biological membranes XXV. Enhanced and sustained delivery of trifluorothymidine to the brain using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. el-Koussi A; Bodor N Drug Des Deliv; 1987 May; 1(4):275-83. PubMed ID: 3151241 [TBL] [Abstract][Full Text] [Related]
6. 1, 2-dihydroisoquinoline-N-acetic acid derivatives as new carriers for brain-specific delivery II: delivery of phenethylamine as model drug. Mahmoud S; Sheha M; Aboul-Fadl T; Farag H Arch Pharm (Weinheim); 2003 Jul; 336(4-5):258-63. PubMed ID: 12916061 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brain. El-Sherbeny MA; Al-Salem HS; Sultan MA; Radwan MA; Farag HA; El-Subbagh HI Arch Pharm (Weinheim); 2003 Oct; 336(10):445-55. PubMed ID: 14582121 [TBL] [Abstract][Full Text] [Related]
8. Chemical delivery systems for drugs containing an amino group: synthesis and properties of some pyridine derivatives of desipramine. Pop E; Wu WM; Shek E; Bodor N Drug Des Deliv; 1989 Dec; 5(2):93-115. PubMed ID: 2577990 [TBL] [Abstract][Full Text] [Related]
10. Improved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials. Murakami T; Shek E; Pop E; Bodor N J Pharm Sci; 1989 Sep; 78(9):732-7. PubMed ID: 2585265 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester. Omar FA; Farag HH; Bodor N J Drug Target; 1994; 2(4):309-16. PubMed ID: 7858956 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system. Yiu S; Knaus EE J Med Chem; 1996 Nov; 39(23):4576-82. PubMed ID: 8917646 [TBL] [Abstract][Full Text] [Related]
13. Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents. Woodard PA; Winwood D; Brewster ME; Estes KS; Bodor N Drug Des Deliv; 1990 May; 6(1):15-28. PubMed ID: 2078285 [TBL] [Abstract][Full Text] [Related]
14. Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone). Somogyi G; Buchwald P; Bodor N Pharmazie; 2002 Feb; 57(2):135-7. PubMed ID: 11878190 [TBL] [Abstract][Full Text] [Related]
15. Improved delivery through biological membranes. XXX. Synthesis and biological aspects of a 1,4-dihydropyridine based chemical delivery system for brain-sustained delivery of hydroxy CCNU. Raghavan KS; Shek E; Bodor N Anticancer Drug Des; 1987 Aug; 2(1):25-36. PubMed ID: 3449083 [TBL] [Abstract][Full Text] [Related]
16. N-malonyl-1,2-dihydroisoquinoline as a novel carrier for specific delivery of drugs to the brain. Abdel-Aziz M; Abuo-Rahma Gel-D; Hassan HA; Farag HH Arch Pharm (Weinheim); 2010 Jan; 343(1):54-60. PubMed ID: 19899103 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917 [TBL] [Abstract][Full Text] [Related]
19. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. Zhu XG; Greeley GH; Lewis BG; Lilja P; Thompson JC J Neurosci Res; 1986; 15(3):393-403. PubMed ID: 3754587 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]